These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Apolipoprotein E and cognitive performance: a meta-analysis. Small BJ; Rosnick CB; Fratiglioni L; Bäckman L Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785 [TBL] [Abstract][Full Text] [Related]
45. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD; J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723 [TBL] [Abstract][Full Text] [Related]
46. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains. Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378 [TBL] [Abstract][Full Text] [Related]
47. APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults. Ward DD; Summers MJ; Saunders NL; Janssen P; Stuart KE; Vickers JC Behav Brain Res; 2014 Sep; 271():309-15. PubMed ID: 24946073 [TBL] [Abstract][Full Text] [Related]
48. A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment. Kim SE; Woo S; Kim SW; Chin J; Kim HJ; Lee BI; Park J; Park KW; Kang DY; Noh Y; Ye BS; Yoo HS; Lee JS; Kim Y; Kim SJ; Cho SH; Na DL; Lockhart SN; Jang H; Seo SW J Alzheimers Dis; 2018; 66(2):681-691. PubMed ID: 30320571 [TBL] [Abstract][Full Text] [Related]
49. Intraindividual cognitive decline using a brief computerized cognitive screening test. Darby DG; Pietrzak RH; Fredrickson J; Woodward M; Moore L; Fredrickson A; Sach J; Maruff P Alzheimers Dement; 2012; 8(2):95-104. PubMed ID: 22404851 [TBL] [Abstract][Full Text] [Related]
50. Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants. Chatterjee P; Goozee K; Sohrabi HR; Shen K; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Chung R; Zetterberg H; Blennow K; Martins RN J Alzheimers Dis; 2018; 63(2):479-487. PubMed ID: 29630554 [TBL] [Abstract][Full Text] [Related]
51. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Sprecher KE; Bendlin BB; Racine AM; Okonkwo OC; Christian BT; Koscik RL; Sager MA; Asthana S; Johnson SC; Benca RM Neurobiol Aging; 2015 Sep; 36(9):2568-76. PubMed ID: 26059712 [TBL] [Abstract][Full Text] [Related]
52. Interactive effect of APOE genotype and blood pressure on cognitive decline: the PATH through life study. Andrews S; Das D; Anstey KJ; Easteal S J Alzheimers Dis; 2015; 44(4):1087-98. PubMed ID: 25672766 [TBL] [Abstract][Full Text] [Related]
53. Identifying cost-effective predictive rules of amyloid-β level by integrating neuropsychological tests and plasma-based markers. Haghighi M; Smith A; Morgan D; Small B; Huang S J Alzheimers Dis; 2015; 43(4):1261-70. PubMed ID: 25147105 [TBL] [Abstract][Full Text] [Related]
54. Cognitive decline and amyloid accumulation in patients with mild cognitive impairment. Koivunen J; Karrasch M; Scheinin NM; Aalto S; Vahlberg T; Någren K; Helin S; Viitanen M; Rinne JO Dement Geriatr Cogn Disord; 2012; 34(1):31-7. PubMed ID: 22868352 [TBL] [Abstract][Full Text] [Related]
55. Association Between Serum Triglycerides and Cerebral Amyloidosis in Cognitively Normal Elderly. Choi HJ; Byun MS; Yi D; Choe YM; Sohn BK; Baek HW; Lee JH; Kim HJ; Han JY; Yoon EJ; Kim YK; Woo JI; Lee DY Am J Geriatr Psychiatry; 2016 Aug; 24(8):604-612. PubMed ID: 27311886 [TBL] [Abstract][Full Text] [Related]
56. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951 [TBL] [Abstract][Full Text] [Related]
57. Midlife insulin resistance, Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033 [TBL] [Abstract][Full Text] [Related]
58. CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease. Liu C; Cholerton B; Shi M; Ginghina C; Cain KC; Auinger P; ; Zhang J Parkinsonism Relat Disord; 2015 Mar; 21(3):271-6. PubMed ID: 25596881 [TBL] [Abstract][Full Text] [Related]
59. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study. Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392 [TBL] [Abstract][Full Text] [Related]